Benzyl 4-oxo-2-(trifluoromethyl)piperidine-1-carboxylate, 95.0%, 1g

5-Amino-2-(phenylamino)benzenesulfonic acid, 95+%, 5g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine, 98.0%, 100g

1,3-Propanesultone>99.0%(GC)25g

cis-4-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid, 97.0%, 250mg

4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid, 90.0%, 5g

2,6-Dibromobenzoic acid, 97.0%, 100g

7-Methyl-8-nitroquinoline>98.0%(GC)(T)5g

4-Acetylthiazole, 98.0%, 10g

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

Tert-butyl (2R,3R)-3-hydroxy-2-methylpyrrolidine-1-carboxylate, 98%, 500mg

2-Ethoxycarbonylbenzeneboronic acid, 98.0%, 1g

(S)-1-(tert-Butoxycarbonyl)-2-(2-nitrobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 1g